GW501516 20 mg

Dragon Pharma GW501516 – PPARδ Agonist for Metabolic and Endurance Research

Dragon Pharma GW501516 20 mg is a high-purity oral formulation of GW501516, also known as Cardarine, a selective peroxisome proliferator-activated receptor delta (PPARδ) agonist. Each tablet delivers 20 mg of GW501516, with 100 tablets per sachet. This compound is extensively studied for its effects on metabolic regulation, fatty acid oxidation, and oxidative muscle fiber switching in research models.

GW501516 activates PPARδ receptors, which play a key role in regulating lipid metabolism, glucose homeostasis, and energy expenditure. Activation of this pathway promotes the expression of genes involved in fatty acid oxidation and increases oxidative muscle fiber formation. For researchers studying metabolic pathways, endurance mechanisms, or lipid metabolism, Dragon Pharma GW501516 20 mg delivers a well-characterized research compound. When researchers seek legit Cardarine for advanced metabolic studies, Dragon Pharma provides batch-traceable, third-party verified tablets.

Why Athletes & Bodybuilders Are Researching GW501516

Within performance research communities, GW501516 is studied for its ability to enhance fatty acid oxidation and improve endurance capacity. Research focuses on its PPARδ-mediated effects on oxidative muscle fibers, metabolic switching, and lipid utilization in animal models.

What Makes Dragon Pharma GW501516 20 mg Different?

• ✔ Selective PPARδ agonist – Specifically targets PPARδ pathways for metabolic research.
• ✔ Oral bioavailability – Convenient administration for research protocols.
• ✔ Fatty acid oxidation research – Promotes expression of genes involved in lipid metabolism.
• ✔ Third-party lab verified – Independent testing for potency and purity.

For researchers requiring a selective PPARδ agonist for metabolic and endurance research, legit GW501516 from Dragon Pharma delivers a professionally manufactured, lab-verified research compound.

Product Specifications

Dosage & Research Guidelines

Research Dosing Guidelines

Typical GW501516 research dosing in animal models ranges from 1–10 mg per kg of body weight. Due to its approximately 16-24 hour half-life, once daily administration is common.

• ✔ Oral administration – Standard route for GW501516 research
• ✔ One sachet provides 2000 mg total GW501516 (100 x 20 mg tablets)
• ✔ Research cycles typically run 4-8 weeks for metabolic studies
• ✔ Once daily administration due to half-life

Dosing Guide

Using 20 mg tablets:

• ✔ 0.25 tablet = 5 mg GW501516
• ✔ 0.5 tablet = 10 mg GW501516
• ✔ 0.75 tablet = 15 mg GW501516
• ✔ 1 tablet = 20 mg GW501516
• ✔ 1.5 tablets = 30 mg GW501516
• ✔ 2 tablets = 40 mg GW501516
• ✔ Administer orally according to research protocol

How Researchers Are Using GW501516

GW501516 is studied for its PPARδ-mediated effects on fatty acid oxidation and endurance capacity. Researchers investigate its role in metabolic switching and oxidative muscle fiber formation.

Popular research stacks include:

• ✔ GW501516 + SR9009 – for combined PPARδ and circadian rhythm metabolic research. View SLU-PP 332 →
• ✔ GW501516 + Cardarine – for dose-response PPARδ activation studies. View GW501516 →
• ✔ GW501516 + MK 677 – for combined metabolic and GH secretagogue research. View MK 677 →

Research Protocol Example (6 Weeks)

• ✔ Weeks 1-6: GW501516 – 10-20 mg administered daily via oral route
• ✔ Weeks 1-6: SR9009 – 10-20 mg twice daily (optional for circadian metabolic studies)
• ✔ Washout period: 1-2 weeks for GW501516 clearance

Important Considerations

• 🔬 Selective PPARδ agonist – activates fatty acid oxidation pathways in research models
• 💧 Oral bioavailability – convenient administration for research protocols
• ⚠️ 16-24 hour half-life – once daily administration sufficient for sustained studies
• 📦 Upregulates genes involved in lipid metabolism and oxidative muscle fiber formation
• 📦 Always source Dragon Pharma GW501516 20 mg from verified suppliers with batch traceability

Lab Verification – Third-Party Test Results

At Dragon Pharma, every batch of GW501516 20 mg undergoes independent third-party HPLC testing to verify potency, purity, and content uniformity. Below are test results for the current batch, analyzed by Janoshik.

Lab file

gw501516-lab-test-2024-06-18

Test Date

2024-06-18

Batch Number

HDGW23

Measured Result

21.70 mg

Assay vs Label

108.50%

COA summary: potency verified (21.70 mg/tablet), purity passed, content uniformity confirmed.

Latest Batch

Why Third-Party Testing Matters

PPARδ agonists are frequently counterfeited due to their research demand. Independent laboratory verification is the only reliable method to confirm potency and purity. Dragon Pharma commits to full transparency – every batch is tested, and COAs are published here as they become available.

For more information on PPARδ research and metabolic pathways, refer to this PubMed study on PPARδ signaling.

Shipping & Product Authenticity

What to Expect

• ✔ Orders processed within 24–48 hours after payment confirmation
• ✔ USA Domestic shipping via USPS/UPS/FedEx – tracking included
• ✔ International tracking available (update frequency varies by destination)
• ✔ Sachets shipped in protective packaging with tamper-evident seals
• ✔ Tablets shipped at ambient temperature – store properly upon arrival

How to Verify You Have Legit GW501516 20 mg

Counterfeit PPARδ agonists are a real problem. Here's how to confirm you are getting authentic Dragon Pharma GW501516 20 mg:

• ✔ QR code verification – each sachet includes a unique QR code. Scan it to verify the batch on Dragon Pharma's official database
• ✔ Scratch-off serial number – reveals a one-time use code for online verification
• ✔ Batch traceability – match the batch number on the sachet to lab test results above
• ✔ Original sealed sachet – tamper-evident packaging with Dragon Pharma labeling

For complete delivery details, tracking policy, international customs, and reshipment terms, please see our Shipping Info page.

Storage Guidelines

Storage Recommendations

• ✔ Store at 15–25°C (59–77°F) – controlled room temperature
• ✔ Keep in original sachet packaging, away from light and moisture
• ✔ Do not refrigerate – refrigeration may introduce moisture
• ✔ Stable for up to 24 months when stored properly
• ✔ Avoid repeated temperature fluctuations

What to Avoid

• ❌ Exposure to high humidity – tablets may degrade
• ❌ Leaving at extreme temperatures (>30°C) – accelerates degradation
• ❌ Storing in bathroom or near heat sources
• ❌ Using tablets that appear discolored or show signs of moisture damage
• ❌ Opening the sachet before ready to use – keep sealed until needed

Inspection Before Use

Before using in your research, always inspect the sachet and tablets:

• ✔ Sachet should be sealed and intact – do not use if seal is broken or damaged
• ✔ Tablets should be uniform in appearance, free from discoloration or visible defects
• ✔ Check batch number and QR code for authenticity before first use

Keep out of reach of children and unauthorized personnel. Follow institutional laboratory safety guidelines for handling research compounds.

Frequently Asked Questions